- Hypertension
- Prophylaxis of angina/angina treatment
- Verapamil is used in the treatment of some arrhythmias
- Nimodipine is used for the prevention of ischaemic neurological deficits following subarachnoid haemorrhage
Short acting formulations of Dihydropyridines are
not recommended for use.
Diltiazem 2% cream is also used unlicensed for the treatment of anal fissures.
Contraindications:
- Aortic stenosis
- Non-dihydropyridines are contraindicated in patients with bradyarrhythmias and heart failure
- Avoid after recent myocardial infarction
Caution:
Individual drugs may have other contraindications, including safety in pregnancy / breast feeding.
Calcium channel antagonists block the L-type voltage sensitive calcium channels on the myocardium, vascular and smooth muscle cells. The Dihydropyridine calcium channel blockers have a vasodilatory action and have no effect on the on cardiac contractility or conduction. In comparison, Verapamil and Diltiazem (to a lesser degree) are poor vasodilators but depress cardiac conduction and contractility.
The vasodilatation action of the Dihydropyridines has the effect of reducing venous return which in turn reduces left ventricular work load.

Oral (verapamil and diltiazem are available as intravenous preparations).
The brand of diltiazem and nifedipine must be stated on the prescription as each brand has varying bioavailability.
The main side effects are caused by widespread vasodilatation:
- Flushing
- Dizziness
- Hypotension
- Ankle swelling (note this is not due to oedema)
- Headache
These effects can be minimised by starting patients on a low dose and titrating up.
Dihydropyridines can cause gum hyperplasia.
Verapamil and Diltiazem may cause worsening of heart failure and heart block / bradycardia.
Verapamil may cause constipation.
All types of calcium channel blockers (but not all individual drugs) can increase plasma Digoxin and Ciclosporin concentrations, which may precipitate toxicity.
All calcium channel blockers will potentiate the action of other hypotensive agents.
Verapamil and Diltiazem should not be prescribed with beta blockers as this may cause significant reduction in heart rate and a fall in cardiac output. Similar issues can occur with Amiodarone.
Both Verapamil and Diltiazem can increase the risk of myositis if given with statins.
All calcium channel blockers can be involved in drug-drug (and drug-food) interactions via the cytochrome P450 system. Possible interactions should be checked prior to prescribing.
Inform any patient who is treated with a Dihydropyridine calcium channel blockers to avoid grapefruit juice.
Warn the patient about the side effects of ankle swelling and headaches.
The metabolism of Dihydropyridines (except Amlodipine) and Verapamil is affected by grapefruit juice and other enzyme inhibitors.